Sleep Quality & Psoriatic Arthritis
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
Read more →What's hot
View all perspectives
What's Hot
Ultrasound in PsA
Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Watch video →
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Watch video →
Sunday (Day 2): ACR 22 Daily Recap
ACR 2022 Daily Recap for Sunday, November 13th. Panelists: Drs. Robert Chao, Antoni Chan, Bella Mehta, Janet Pope, Yuz Yusof, Cassy Sims, Akhil Sood, Sheila Reyes and Jack Cush.
Watch video →
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Watch video →
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Watch video →
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Watch video →
PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Watch video →
ACR22 Daily Recap: Saturday Recap
Panelists: Drs. Jack Cush, Michael Putman, Eric Dein, Patricia Harkins and Rachel Tate.
Watch video →
Julian Segan JulianSegan
3 years 1 month ago
Review meds in someone with a flare of cutaneous lupus. These common meds can be culprits.
@RheumNow #ACR22 #Pearls https://t.co/IUer9OqA5W
Dr. Rachel Tate uptoTate
3 years 1 month ago
Abs 0381 at #ACR22 Suggests that ASDAS superior to BASDAI in clinical practice based on gender outcomes. Female gender assoc'd w/ less favorable outcomes across the SpA spectrum, except for CRP. What do you use in clinical practice? @RheumNow https://t.co/HzjPq9KbAH https://t.co/9MU93MkxFN
Aurelie Najm AurelieRheumo
3 years 1 month ago
Song et al. : cit-specific CD4+ T cells activated & expanded in CCP+ at-risk RA, CCP+ RA converters and early RA pts.
Circulating Ag specific CD4+ T cells < RA converters vs. at-risk pts. Could this be due to migration in the joints?
https://t.co/Vp0Rbwv6RB
#0498 #ACR22 @Rheumnow https://t.co/NoN1ocjC70
Julian Segan JulianSegan
3 years 1 month ago
45% of unselected idiopathic uveitis found to have underlying SpA. Don't stop thinking at the diagnosis of AAU.
@RheumNow #ACR22 #Pearls https://t.co/w9zXz6gzUX
TheDaoIndex KDAO2011
3 years 1 month ago
#RheumPearl: Pattern of uveitis differs in different SpA Dr. J Kolfenbach #ACR22 @rheumnow https://t.co/Au5zfX2Q5Z
Julian Segan JulianSegan
3 years 1 month ago
In early hip OA, look for underlying FAI (amongst other secondary causes. Surgical intervention however is very controversial.
@RheumNow #ACR22 #Pearls https://t.co/Gg4EtbnGiT
Richard Conway RichardPAConway
3 years 1 month ago
Aggarwal @docrota et al. TYK2/JAK1i brepoctinib in dermatomyositis. Supportive clinical and pharmacological evidence, plus efficacy of other JAK agents, likely to lead to a clinical trial. @rheumnow #ACR22 Abstr#0157 https://t.co/Tz6dHfyUmq https://t.co/0R0tcuCe6D
Dr. Rachel Tate uptoTate
3 years 1 month ago
"Behind the difficult to treat RA is a person!" Dr. Iris Navarro-Millán, MD reminds us to treat the patient, not just the disease! #ACR22 @RheumNow
TheDaoIndex KDAO2011
3 years 1 month ago
#RheumPearl FVC:DLCO ratio can be helpful to disting. b/t ILD and PAH. FVC:DLCO = 1 is seen in ILD. when the ratio > 1.6, typically assc with pulm vasc dz (e.g, PE, PAH) #ACR22 @rheumnow https://t.co/a7JJCLtv2N
Patricia Harkins DrTrishHarkins
3 years 1 month ago
🌟Subclinical GCA in PMR🌟
👉25pts PMR
👉US of TA and AX arteries
💥5(20%) US evidence of GCA (TA in 5/5, AX in 1/5)
💥1yr f/up -all 5 developed clinical GCA
❓Time to rethink our assessment of PMR pts ❓
Abst#0478
#ACR22 @RheumNow @colmkirby22
#ACRbest https://t.co/PynxF7wIck
Dr. Rachel Tate uptoTate
3 years 1 month ago
Dr. Kolfenbach reminds us that scleritis isn't always red or painful! #ACR22 @RheumNow https://t.co/B5N0wE7LOL
TheDaoIndex KDAO2011
3 years 1 month ago
The next edition is in press. reserve your copy! Dr. Stone shared that he dedicated the book to his mom who died from SSc. #ACR22 @rheumnow https://t.co/i24lNAc7Qv
Aurelie Najm AurelieRheumo
3 years 1 month ago
4/6 pts with PsA have poor sleep quality (!) (PSQI)
Asso w/ female, > enthesitis, > dis activity, fatigue, anxiety or depression.
1/2 = no ttmt for insomnia.
Multimodal interventions incl psychological support are key!
https://t.co/z5V9SKur3G
Abstr #0387 #ACR22 @Rheumnow https://t.co/CsTZkHjnn6
Julian Segan JulianSegan
3 years 1 month ago
Pearl: ANCA vasculitis may present initially as a migratory arthritis
@RheumNow #ACR22 #Pearls https://t.co/259ZNUcEMB
David Liew drdavidliew
3 years 1 month ago
Systemic autoimmune dx/'CTDs':
We attach lots of legacy labels, but most aren't pure/neatly in boxes.
We can do better:
immunophenotyping: FACS n=235 🇯🇵
unsupervised clustering
Within clusters: better phenotypes, varied labels.
This has to be the future
ABS0506 #ACR22 @RheumNow https://t.co/YUTVN1dWCh
Poster Hall